Investor portfolio
Baker Bros. Advisors
Baker Bros. Advisors is an investment adviser associated with Julian Baker and Felix Baker, widely known for healthcare and biotechnology investing.
Linked investors: Felix Baker , Julian Baker
US 13F portfolio
- Quarter
- Q3 2026
- Filed
- 2026-11-16
- Portfolio value
- $21,044,442,318
- Positions
- 80
- Sources
- 13F on EDGAR
| history | Ticker | Change | % of portfolio |
|---|---|---|---|
| ≡ | SRZNW | SOLD | — |
| ≡ | SKYE | SOLD | — |
| ≡ | WVE | SOLD | — |
| ≡ | SGMT | SOLD | — |
| ≡ | VSTM | SOLD | — |
| ≡ | SION | SOLD | — |
| ≡ | VRDN | SOLD | — |
| ≡ | ALMS | SOLD | — |
| ≡ | CRNX | SOLD | — |
| ≡ | TYRA | 0.0% | |
| ≡ | Unmapped CUSIP | Newly reported | 0.0% |
| ≡ | ALGS | 0.0% | |
| ≡ | TCRX | 0.0% | |
| ≡ | SANA | 0.0% | |
| ≡ | IMNM | 0.01% | |
| ≡ | EIKN | 0.02% | |
| ≡ | QTTB | Newly reported | 0.02% |
| ≡ | VTVT | 0.02% | |
| ≡ | CERS | −64% | 0.03% |
| ≡ | TARA | +90% | 0.03% |
| ≡ | LBRX | 0.04% | |
| ≡ | TNGX | 0.04% | |
| ≡ | AVTX | 0.04% | |
| ≡ | AVLN | 0.05% | |
| ≡ | NTLA | −11% | 0.05% |
| ≡ | EVMN | +46% | 0.05% |
| ≡ | SERA | 0.05% | |
| ≡ | BNTX | 0.06% | |
| ≡ | MPLT | +220% | 0.06% |
| ≡ | Unmapped CUSIP | Newly reported | 0.06% |
| ≡ | Unmapped CUSIP | Newly reported | 0.06% |
| ≡ | DYN | 0.06% | |
| ≡ | CTMX | 0.06% | |
| ≡ | XENE | 0.07% | |
| ≡ | CYTK | 0.07% | |
| ≡ | TECX | 0.07% | |
| ≡ | PBLS | 0.08% | |
| ≡ | Unmapped CUSIP | Newly reported | 0.08% |
| ≡ | DBVT | 0.08% | |
| ≡ | JBIO | 0.08% | |
| ≡ | AKTS | 0.09% | |
| ≡ | TSHA | 0.09% | |
| ≡ | GENB | 0.1% | |
| ≡ | RCUS | 0.1% | |
| ≡ | IRON | 0.11% | |
| ≡ | ABSI | 0.11% | |
| ≡ | FTH | −38% | 0.11% |
| ≡ | XNCR | 0.13% | |
| ≡ | NGNE | 0.13% | |
| ≡ | TRDA | 0.15% | |
| ≡ | STOK | −61% | 0.16% |
| ≡ | IMTX | −55% | 0.18% |
| ≡ | DSGN | +12% | 0.18% |
| ≡ | MIRM | 0.18% | |
| ≡ | PRLD | 0.19% | |
| ≡ | BCYC | 0.19% | |
| ≡ | ELVN | 0.2% | |
| ≡ | GPCR | 0.21% | |
| ≡ | IONS | −50% | 0.22% |
| ≡ | RLAY | 0.24% | |
| ≡ | GLUE | 0.25% | |
| ≡ | RAPP | 0.25% | |
| ≡ | Unmapped CUSIP | 0.26% | |
| ≡ | DNTH | 0.36% | |
| ≡ | DNLI | 0.37% | |
| ≡ | CLDX | +117% | 0.4% |
| ≡ | IMVT | −49% | 0.44% |
| ≡ | NRIX | 0.52% | |
| ≡ | ARWR | −14% | 0.53% |
| ≡ | ROIV | −22% | 0.64% |
| ≡ | REPL | 0.69% | |
| ≡ | EWTX | 0.71% | |
| ≡ | IDYA | 0.91% | |
| ≡ | KNSA | 1.0% | |
| ≡ | CELC | −39% | 1.82% |
| ≡ | ALKS | 1.93% | |
| ≡ | ABCL | +0% | 2.29% |
| ≡ | PRAX | 2.43% | |
| ≡ | RYTM | 2.54% | |
| ≡ | SMMT | 2.63% | |
| ≡ | GRAL | 2.68% | |
| ≡ | ACAD | 4.11% | |
| ≡ | KYMR | 4.6% | |
| ≡ | INSM | 4.77% | |
| ≡ | MDGL | 5.13% | |
| ≡ | KOD | +10% | 9.85% |
| ≡ | RVMD | −7% | 10.38% |
| ≡ | ONC | +0% | 15.36% |
| ≡ | INCY | +0% | 17.74% |
13F filings show only a manager's disclosed reportable long positions; this filing contains no call or put rows — methodology & caveats.